Indaptus Therapeutics FY EPS $(1.83) Beats $(1.95) Estimate; Cash Balance Of $13.4M Will Provide Runway Through Q3 Of 2024
Indaptus Therapeutics FY EPS $(1.83) Beats $(1.95) Estimate; Cash Balance Of $13.4M Will Provide Runway Through Q3 Of 2024
Indaptus Therapeutics财年每股收益美元（1.83美元）超过预期（1.95美元）；1340万美元的现金余额将为2024年第三季度提供资金支持
Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(1.83) per share which beat the analyst consensus estimate of $(1.95) by 6.15 percent. This is a 5.78 percent decrease over losses of $(1.73) per share from the same period last year.
Indaptus Therapeutics（纳斯达克股票代码：INDP）公布的季度亏损为每股1.83美元，比分析师共识估计的美元（1.95美元）高出6.15％。这比去年同期每股亏损1.73美元（1.73美元）下降了5.78％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。